AHA Coding Clinic® for ICD-9 - 2006 Quarter 4; VOLUMES 1 AND 2 NEW/REVISED CODES
Diseases of White Blood Cells
The patient developed neutropenia following chemotherapy and was given Pegfilgrastim therapy for the neutropenia. What is the correct code assignment for neutropenia secondary to chemotherapy? ...
Subscribe or sign in to view the full article.
Article Overview
This premium article reviews a set of October 1, 2006 changes to the white blood cell disease category and explains the broader clinical context for classifying abnormal white blood cell findings. It is aimed at coders and other revenue cycle professionals who need to understand the scope of the revised category, the new subcategories and codes, and the general kinds of documentation or clinical correlation discussed in the update. The article also includes a coding question about neutropenia after chemotherapy and references related diagnosis coding concepts.
Why This Topic Matters
Accurate reporting of white blood cell disorders can depend on the specific type of count abnormality, the underlying cause, and whether the finding is clinically significant. This article helps readers navigate a revision that affects how these conditions are organized and recognized in coding workflows.
Article Sections
-
Effective date and scope of changes
Introduces the timing of the update and the broad categories of white blood cell disorders affected by the revision.
-
Clinical background on white blood cells
Provides general background on white blood cell function and broad clinical reasons white blood cell production may be reduced or increased.
-
Documentation and laboratory significance
Discusses the importance of clinical concurrence and cautions about relying on laboratory findings alone.
-
ICD-9-CM category 288 revisions
Outlines the revised white blood cell disease category, including new subcategories and code groups for low and elevated white blood cell counts and related syndromes.
-
Coding question: neutropenia after chemotherapy
Presents a brief coding scenario involving neutropenia in the setting of chemotherapy and the related diagnosis coding context.
What You Will Learn
- How the white blood cell disease category was updated in the 2006 revision
- Which broad types of white blood cell abnormalities are addressed in the article
- What clinical documentation considerations are highlighted for these diagnoses
- How the article frames a chemotherapy-related neutropenia scenario
Who Should Read This
- Medical coders
- Coding auditors
- Revenue cycle staff
- Clinical documentation specialists
- Healthcare compliance professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.

Quick, Current, Complete - www.findacode.com